Sign up Australia
Proactive Investors - Run By Investors For Investors
Why invest in BCT?
Bluechiip: THE INVESTMENT CASE

Bluechiip: Access latest PPT from Proactive's CEO Sessions

Andrew McLellan discussed with investors wiresless tracking technology.
Bluechiip: Access latest PPT from Proactive's CEO Sessions
INVESTMENT OVERVIEW: BCT The Big Picture
Andrew McLellan, MD, bluechiip

Bluechiip's (ASX:BCT) managing director, Andrew McLellan, joined Proactive's CEO Sessions in Sydney on Tuesday 14th March and Melbourne on Wednesday 15th March.

Bluechiip has developed an IT based temperature and identification tracking solution for biosamples in the health and life sciences industry.

The company has a growing partner pipeline and growing revenues.

 

ACCESS THE FULL PRESENTATION HERE

 



Register here to be notified of future BCT Company articles
View full BCT profile

Bluechiip Timeline

Newswire
August 11 2016
Newswire
December 15 2015
Newswire
September 16 2015
Newswire
August 28 2014

Related Articles

shutterstock_302650592_58dc0a99d5fca.jpg
March 30 2017
This week the firm has bolstered its coffers to the tune of over $20mln via a now closed bought deal financing.
the word wealth seen through the lens of a pair of spectacles.
May 31 2016
The company is gaining critical mass purchasing independent financial advisers and then plugging them into its discretionary fund management operation.
Call service droids
March 09 2017
Between now and 2018, Panmure Gordon sees a compound annualised growth rate for profit in excess of 100%

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use